2m 2m 2m 2m 2m 2m 2m
OVID THERAPTCS (OVID)
NASDAQ
$2.41+$0.01 (+0.58%)
Price as of Jun 03, 2026 7:08 PM EDT- $509.5MMarket Cap
- 703.48%1-Year Change
- BiotechnologyIndustry
OVID THERAPTCS (OVID)
$2.41+$0.01 (+0.58%)
OVID | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.40 | ||
Change | -$0.16 (-6.25%) | ||
Open | $2.55 | ||
High | $2.63 | ||
Low | $2.37 | ||
Previous Close | $2.56 | ||
Volume | 1,416,711 | ||
30-Day Average Volume | 1,825,441 | ||
1-Week Change | -2.04% | ||
1-Month Change | -13.98% | ||
1-Year Change | 703.48% | ||
3-Year Change | -34.52% | ||
5-Year Change | -45.70% | ||
Fundamentals | |||
Shares Outstanding | 186.6M | ||
Total Assets | $225.6M | ||
Market Cap | $509.5M | ||
Enterprise Value | $415.5M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$17.0M | ||
Free Cash Flow | -$13.9M | ||
EBIT | -$17.0M | ||
EBITDA | -$17.0M | ||
Net Working Capital | $144.4M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 3 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -37 | ||
Price/Operating Cash Flow | -37 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue